132 related articles for article (PubMed ID: 38331105)
21. Fuzheng Xiaoai Decoction 1 ameliorated cancer cachexia-induced muscle atrophy via Akt-mTOR pathway.
Cheng QQ; Mao SL; Yang LN; Chen L; Zhu JZ; Liu X; Hou AJ; Zhang RR
J Ethnopharmacol; 2023 Mar; 303():115944. PubMed ID: 36410574
[TBL] [Abstract][Full Text] [Related]
22. Valproic acid attenuates skeletal muscle wasting by inhibiting C/EBPβ-regulated atrogin1 expression in cancer cachexia.
Sun R; Zhang S; Hu W; Lu X; Lou N; Yang Z; Chen S; Zhang X; Yang H
Am J Physiol Cell Physiol; 2016 Jul; 311(1):C101-15. PubMed ID: 27122162
[TBL] [Abstract][Full Text] [Related]
23. A Key Role for Leukemia Inhibitory Factor in C26 Cancer Cachexia.
Seto DN; Kandarian SC; Jackman RW
J Biol Chem; 2015 Aug; 290(32):19976-86. PubMed ID: 26092726
[TBL] [Abstract][Full Text] [Related]
24. Magnolol inhibits myotube atrophy induced by cancer cachexia through myostatin signaling pathway in vitro.
Ge Z; Liu D; Shang Y; Li Y; Chen SZ
J Nat Med; 2020 Sep; 74(4):741-749. PubMed ID: 32601830
[TBL] [Abstract][Full Text] [Related]
25. Moderating AKT signaling with baicalein protects against weight loss by preventing muscle atrophy in a cachexia model caused by CT26 colon cancer.
Song G; Park WY; Jiao W; Park JY; Jung SJ; Ma S; Lee J; Lee KY; Choe SK; Park J; Kwak HJ; Ahn KS; Um JY
Biochim Biophys Acta Mol Cell Res; 2024 Mar; 1871(3):119670. PubMed ID: 38220095
[TBL] [Abstract][Full Text] [Related]
26. Myostatin is a novel tumoral factor that induces cancer cachexia.
Lokireddy S; Wijesoma IW; Bonala S; Wei M; Sze SK; McFarlane C; Kambadur R; Sharma M
Biochem J; 2012 Aug; 446(1):23-36. PubMed ID: 22621320
[TBL] [Abstract][Full Text] [Related]
27. Jianpi Decoction Combined with Medroxyprogesterone Acetate Alleviates Cancer Cachexia and Prevents Muscle Atrophy by Directly Inhibiting E3 Ubiquitin Ligase.
Li Q; Kong ZD; Wang H; Gu HH; Chen Z; Li SG; Chen YQ; Cai Y; Yang ZJ
Chin J Integr Med; 2024 Jun; 30(6):499-506. PubMed ID: 37612478
[TBL] [Abstract][Full Text] [Related]
28. Handelin alleviates cachexia- and aging-induced skeletal muscle atrophy by improving protein homeostasis and inhibiting inflammation.
Zhang HJ; Wang BH; Wang X; Huang CP; Xu SM; Wang JL; Huang TE; Xiao WL; Tian XL; Lan XQ; Wang QQ; Xiang Y
J Cachexia Sarcopenia Muscle; 2024 Feb; 15(1):173-188. PubMed ID: 38009816
[TBL] [Abstract][Full Text] [Related]
29. Group I Paks support muscle regeneration and counteract cancer-associated muscle atrophy.
Cerquone Perpetuini A; Re Cecconi AD; Chiappa M; Martinelli GB; Fuoco C; Desiderio G; Castagnoli L; Gargioli C; Piccirillo R; Cesareni G
J Cachexia Sarcopenia Muscle; 2018 Aug; 9(4):727-746. PubMed ID: 29781585
[TBL] [Abstract][Full Text] [Related]
30. Anti-inflammatory and immunoregulatory effects of paeoniflorin and total glucosides of paeony.
Zhang L; Wei W
Pharmacol Ther; 2020 Mar; 207():107452. PubMed ID: 31836457
[TBL] [Abstract][Full Text] [Related]
31. Pharmacological Inhibition of HMGB1 Prevents Muscle Wasting.
Li L; Liu H; Tao W; Wen S; Fu X; Yu S
Front Pharmacol; 2021; 12():731386. PubMed ID: 34867338
[No Abstract] [Full Text] [Related]
32. Development of a traditional Chinese medicine-based agent for the treatment of cancer cachexia.
Wu KC; Chu PC; Cheng YJ; Li CI; Tian J; Wu HY; Wu SH; Lai YC; Kao HH; Hsu AL; Lin HW; Lin CH
J Cachexia Sarcopenia Muscle; 2022 Aug; 13(4):2073-2087. PubMed ID: 35718751
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of Stat3 activation suppresses caspase-3 and the ubiquitin-proteasome system, leading to preservation of muscle mass in cancer cachexia.
Silva KA; Dong J; Dong Y; Dong Y; Schor N; Tweardy DJ; Zhang L; Mitch WE
J Biol Chem; 2015 Apr; 290(17):11177-87. PubMed ID: 25787076
[TBL] [Abstract][Full Text] [Related]
34. Tumour-derived leukaemia inhibitory factor is a major driver of cancer cachexia and morbidity in C26 tumour-bearing mice.
Kandarian SC; Nosacka RL; Delitto AE; Judge AR; Judge SM; Ganey JD; Moreira JD; Jackman RW
J Cachexia Sarcopenia Muscle; 2018 Dec; 9(6):1109-1120. PubMed ID: 30270531
[TBL] [Abstract][Full Text] [Related]
35. R-ketorolac ameliorates cancer-associated cachexia and prolongs survival of tumour-bearing mice.
Chrysostomou SE; Eder S; Pototschnig I; Mayer AL; Derler M; Mussbacher M; Schauer S; Zhang D; Yan D; Liu G; Hoefler G; Weichhart T; Vesely PW; Zhang L; Schweiger M
J Cachexia Sarcopenia Muscle; 2024 Apr; 15(2):562-574. PubMed ID: 38302863
[TBL] [Abstract][Full Text] [Related]
36. Ameliorating cancer cachexia by inhibiting cancer cell release of Hsp70 and Hsp90 with omeprazole.
Liu Z; Xiong J; Gao S; Zhu MX; Sun K; Li M; Zhang G; Li YP
J Cachexia Sarcopenia Muscle; 2022 Feb; 13(1):636-647. PubMed ID: 34729960
[TBL] [Abstract][Full Text] [Related]
37. Lung cancer-derived extracellular vesicles induced myotube atrophy and adipocyte lipolysis via the extracellular IL-6-mediated STAT3 pathway.
Hu W; Ru Z; Zhou Y; Xiao W; Sun R; Zhang S; Gao Y; Li X; Zhang X; Yang H
Biochim Biophys Acta Mol Cell Biol Lipids; 2019 Aug; 1864(8):1091-1102. PubMed ID: 31002945
[TBL] [Abstract][Full Text] [Related]
38. Ursolic Acid Alleviates Cancer Cachexia and Prevents Muscle Wasting via Activating SIRT1.
Tao W; Ouyang Z; Liao Z; Li L; Zhang Y; Gao J; Ma L; Yu S
Cancers (Basel); 2023 Apr; 15(8):. PubMed ID: 37190306
[TBL] [Abstract][Full Text] [Related]
39. Continuous Release of Tumor-Derived Factors Improves the Modeling of Cachexia in Muscle Cell Culture.
Jackman RW; Floro J; Yoshimine R; Zitin B; Eiampikul M; El-Jack K; Seto DN; Kandarian SC
Front Physiol; 2017; 8():738. PubMed ID: 28993738
[TBL] [Abstract][Full Text] [Related]
40. Curcumin treatment suppresses cachexia-associated adipose wasting in mice by blocking the cAMP/PKA/CREB signaling pathway.
Wang R; Wei L; Wazir J; Li L; Song S; Lin K; Pu W; Zhao C; Su Z; Zhao Q; Wang H
Phytomedicine; 2023 Jan; 109():154563. PubMed ID: 36610148
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
